FDA Commissioner Stephen Hahn, MD, appeared before the Senate Health, Education, Labor and Pensions Committee June 30 to explain the agency’s vaccine approval requirements. Here are four things to know about what he said:
- To receive full approval, a COVID-19 vaccine will have to prevent the disease or lessen its severity in at least 50 percent of people who receive it.
- Vaccine developers will need to closely monitor their vaccine’s effectiveness and safety after winning approval.
- The FDA expects vaccine developers to involve trial participants who are diverse in race and age.
- The agency still considers emergency use authorizations, and any decisions made regarding temporary approvals will be made on a case-by-case basis.
More articles on pharmacy:
Coalition of drugmakers to unveil $1B venture to pursue antibiotics
Gilead’s remdesivir pricing could set a disruptive industry precedent
CVS Health reportedly launching a GPO called Zinc
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
